Precision therapy in advanced urothelial cancer-Reference-Cited by-同舟云学术

Precision therapy in advanced urothelial cancer

Published:2019-03-04 Issue:2 Volume:4 Page:81-93
ISSN:2380-8993
Container-title:Expert Review of Precision Medicine and Drug Development
language:en
Short-container-title:Expert Review of Precision Medicine and Drug Development

Author:

Schiff Joshua P.¹,Barata Pedro C.¹,Yu Evan Y.²,Grivas Petros²^ORCID

Affiliation:

1. Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA

2. Department of Medicine, Division of Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA, USA

Funder

manuscript was not funded

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23808993.2019.1582298

Reference112 articles.

1. Bladder cancer

2. Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

3. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

4. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset

5. Comprehensive molecular characterization of urothelial bladder carcinoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should Upper-tract Urothelial Carcinoma and Bladder Carcinoma Be Treated the Same or Different?;European Urology Oncology;2021-04

2. Emerging biomarkers in urothelial carcinoma: Challenges and opportunities;Cancer Treatment and Research Communications;2020

3. Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet?;BJU International;2019-08-22

4. Role of Targeted Therapies in Management of Metastatic Urothelial Cancer in the Era of Immunotherapy;Current Treatment Options in Oncology;2019-06-28